Nureca Ltd.
NSE: NURECA | BSE: 543264
₹293.80
₹-9.10
(-3.00%)
As on 30-Oct-2026IST
Market cap
₹285 Cr
Revenue (TTM)
₹174 Cr
P/E Ratio
59.9
P/B Ratio
1.5
Div. Yield
0 %
Quality Score
2/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
1.1 %
-
ROCE
3.3 %
-
Industry P/E
59.9
-
EV/EBITDA
17.3
-
Debt to Equity
0
-
Book Value
₹196.9
-
EPS
₹5
-
Face value
10
-
Shares outstanding
9,541,920
9 Years Aggregate
CFO
₹20.07 Cr
EBITDA
₹107.31 Cr
Net Profit
₹99.95 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nureca
| -4.6 | -18.7 | -10.1 | 12.1 | -4.5 | -29.9 | -- |
|
BSE Healthcare
| 15.5 | -2.1 | -1.3 | 11.3 | 22.5 | 14.9 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Nureca
| 8.3 | -33.0 | -14.1 | -75.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nureca
|
293.8 | 285.1 | 173.9 | 4.8 | 2.2 | 2.6 | 59.9 | 1.5 |
| 294.9 | 196.7 | 34.2 | -4.8 | -11.3 | -30.5 | -- | 11.2 | |
| 102.1 | 194.3 | 55.1 | 5.1 | -- | 7.7 | 38.1 | 2.8 | |
| 253.2 | 138.9 | 45.2 | 7.2 | -- | 49.9 | 15.9 | 2.6 | |
| 116.0 | 159.6 | 43.1 | 6.6 | -- | 40.6 | 32.3 | 2.5 | |
| 1,449.5 | 14,676.1 | 1,997.4 | 307.0 | 16.7 | 10.6 | 46.6 | 4.6 | |
| 512.8 | 1,196.2 | 341.7 | 55.7 | -- | 25.6 | 21.5 | 2.5 | |
| 181.2 | 350.3 | 183.3 | 12.7 | 12.7 | 10.4 | 32.2 | -- | |
| 102.5 | 168.4 | 93.7 | 2.4 | 11.7 | 6.2 | 71.1 | 3.5 | |
| 363.0 | 713.9 | 92.4 | 4.7 | -- | 4.9 | 58.1 | 5.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Nureca IPO: Information Analysis
6 min read•By Danish Khanna
About Nureca
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products;... orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, fitness trackers, and smart weighing scales. In addition, the company provides orthopedic cushions, heating pads, and breast pumps. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India. Read more
-
Incorporated
2016
-
Chairman
Saurabh Goyal
-
Managing Director
Saurabh Goyal
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Nureca Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Nureca
What is the current share price of Nureca Ltd Today?
The share price of Nureca Ltd is ₹293.80 (NSE) and ₹298.80 (BSE) as of 30-Oct-2026 IST. Nureca Ltd has given a return of -4.53% in the last 3 years.
What is the current PB & PE ratio of Nureca Ltd?
The P/E ratio of Nureca Ltd is 59.90 times as on 30-Oct-2026, a 0 premium to its peers’ median range of 59.90 times.
The P/B ratio of Nureca Ltd is 1.52 times as on 30-Oct-2026, a 67 discount to its peers’ median range of 4.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
94.46 |
1.09 |
2025 |
248.64 |
1.08 |
2024 |
0.00 |
1.32 |
2023 |
0.00 |
1.54 |
2022 |
30.30 |
6.70 |
What is the 52 Week High and Low of Nureca Ltd?
The 52-week high and low of Nureca Ltd are Rs 376.00 and Rs 204.00 as of 31-Oct-2026.
What is the market cap of Nureca Ltd?
Nureca Ltd has a market capitalisation of ₹ 285 Cr as on 30-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nureca Ltd?
Before investing in Nureca Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.